Skip to main content
SpringerLink
Log in

Preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed and resectable glioblastoma

  • Correspondence
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Data availability

No datasets were generated or analysed during the current study.

References

  1. Tanaka T, Tamura R, Takei J, Morimoto Y, Teshigawara A, Yamamoto Y et al (2024) An exploratory prospective phase II study of preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed glioblastoma. J Neurooncol 166(3):557–567. https://doi.org/10.1007/s11060-023-04544-8

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Wakabayashi T, Natsume A, Mizusawa J, Katayama H, Fukuda H, Sumi M et al (2018) JCOG0911 INTEGRA study: a randomized screening phase II trial of interferonbeta plus temozolomide in comparison with temozolomide alone for newly diagnosed glioblastoma. J Neurooncol 138(3):627–636. https://doi.org/10.1007/s11060-018-2831-7

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987–996. https://doi.org/10.1056/NEJMoa043330

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

The authors declare that no funds, grants, or other support were received during the preparation of this manuscript.

Author information

Authors and Affiliations

  1. Faculty of Medicine and Health Sciences, McGill University, Montreal, Canada

    Liam Wilson, Aline Atallah & Joan Miguel Romero

Authors
  1. Liam Wilson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Aline Atallah
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Joan Miguel Romero
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

L.W, A.A and J.M.R read the journal article in which this correspondence is based off and contributed to the main points in this correspondence. All authors contributed to the writing of this manuscript and reviewed it’s final version.

Corresponding author

Correspondence to Liam Wilson.

Ethics declarations

Competing interests

The authors declare no competing interests.

Conflict of interests

The authors have no relevant financial or non-financial interests to disclose.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wilson, L., Atallah, A. & Romero, J.M. Preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed and resectable glioblastoma. J Neurooncol (2024). https://doi.org/10.1007/s11060-024-04666-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11060-024-04666-7

Search

Navigation